Submit Manuscript  

Article Details

Rational Drug Design Approach of Receptor Tyrosine Kinase Type III Inhibitors

[ Vol. 26 , Issue. 42 ]


Cheolhee Kim and Eunae Kim*   Pages 7623 - 7640 ( 18 )


Rational drug design is accomplished through the complementary use of structural biology and computational biology of biological macromolecules involved in disease pathology. Most of the known theoretical approaches for drug design are based on knowledge of the biological targets to which the drug binds. This approach can be used to design drug molecules that restore the balance of the signaling pathway by inhibiting or stimulating biological targets by molecular modeling procedures as well as by molecular dynamics simulations. Type III receptor tyrosine kinase affects most of the fundamental cellular processes including cell cycle, cell migration, cell metabolism, and survival, as well as cell proliferation and differentiation. Many inhibitors of successful rational drug design show that some computational techniques can be combined to achieve synergistic effects.


Type III receptor tyrosine kinase, PDGFR, c-KIT, CSF1R, FLT3, rational drug design, computer-aided drug design, molecular modeling, docking simulation, molecular dynamics.


College of Pharmacy, Chosun University, Gwangju 61452, College of Pharmacy, Chosun University, Gwangju 61452

Read Full-Text article